Mitochondrial myopathy biomarkers

Area of Science:

• Biochemistry
• Genetics
• Cell Biology

Background:

• Mitochondrial myopathies are heterogeneous genetic disorders caused by impaired mitochondrial function, affecting energy production and multiple organ systems.
• Beyond bioenergetics, mitochondrial dysfunction impacts biosynthesis, calcium homeostasis, and signaling, contributing to disease complexity and heterogeneity.
• Current diagnostic delays highlight the urgent need for reliable biomarkers in mitochondrial myopathies.

Purpose of the Study:

• To critically evaluate existing and novel biomarkers for mitochondrial myopathies.
• To propose a diagnostic framework to enhance accuracy and streamline patient care.
• To facilitate timely access to treatments and genetic counseling for affected individuals.

Main Methods:

• Comprehensive literature review of current and emerging biomarkers for mitochondrial myopathies.
• Analysis of the pathophysiological roles of mitochondria beyond energy production.
• Development of a proposed diagnostic framework integrating biomarker data.

Main Results:

• Mitochondrial dysfunction has widespread cellular consequences beyond ATP production, contributing to disease heterogeneity.
• Existing biomarkers show promise, but a standardized approach is lacking.
• The proposed framework aims to integrate biomarker data for improved diagnostic accuracy.

Conclusions:

• Reliable biomarkers are essential for accurate and timely diagnosis of mitochondrial myopathies.
• A strategic diagnostic framework can reduce delays and improve patient management.
• Further research into mitochondrial pathophysiology and biomarker development is crucial.